Mostafa Erfani

3.8k total citations
75 papers, 525 citations indexed

About

Mostafa Erfani is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Surgery. According to data from OpenAlex, Mostafa Erfani has authored 75 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Radiology, Nuclear Medicine and Imaging, 26 papers in Oncology and 19 papers in Surgery. Recurrent topics in Mostafa Erfani's work include Radiopharmaceutical Chemistry and Applications (38 papers), Orthopedic Infections and Treatments (14 papers) and Medical Imaging Techniques and Applications (9 papers). Mostafa Erfani is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (38 papers), Orthopedic Infections and Treatments (14 papers) and Medical Imaging Techniques and Applications (9 papers). Mostafa Erfani collaborates with scholars based in Iran, Malaysia and India. Mostafa Erfani's co-authors include Mohammad Shafiei, Davood Beiki, Omid Bavi, Amir Shamloo, Seyed Pezhman Shirmardi, Babak Fallahi, Seyed Esmaeil Sadat Ebrahimi, Omid Sabzevari, Nour Amirmozafari and Mojtaba Shamsaei and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Biology and Bioorganic Chemistry.

In The Last Decade

Mostafa Erfani

69 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mostafa Erfani Iran 13 239 125 107 88 76 75 525
Simon J. Henderson United Kingdom 8 195 0.8× 240 1.9× 87 0.8× 27 0.3× 74 1.0× 13 545
A. Rinelli Italy 11 66 0.3× 159 1.3× 151 1.4× 62 0.7× 31 0.4× 17 621
Takashi Shirakawa Japan 10 65 0.3× 153 1.2× 34 0.3× 82 0.9× 27 0.4× 23 402
Christian Maaß Germany 12 149 0.6× 165 1.3× 72 0.7× 46 0.5× 49 0.6× 18 563
Jiawen Dai China 6 126 0.5× 180 1.4× 173 1.6× 57 0.6× 19 0.3× 7 547
Yewei Liu China 11 105 0.4× 112 0.9× 108 1.0× 35 0.4× 18 0.2× 26 410
Alison Acevedo United States 5 45 0.2× 166 1.3× 112 1.0× 23 0.3× 25 0.3× 8 428
Paul Morrill United Kingdom 11 92 0.4× 177 1.4× 155 1.4× 53 0.6× 23 0.3× 11 418
Yingxia Li China 13 63 0.3× 243 1.9× 65 0.6× 37 0.4× 22 0.3× 33 488
Hojin Jeong South Korea 14 126 0.5× 82 0.7× 100 0.9× 80 0.9× 17 0.2× 43 497

Countries citing papers authored by Mostafa Erfani

Since Specialization
Citations

This map shows the geographic impact of Mostafa Erfani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mostafa Erfani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mostafa Erfani more than expected).

Fields of papers citing papers by Mostafa Erfani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mostafa Erfani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mostafa Erfani. The network helps show where Mostafa Erfani may publish in the future.

Co-authorship network of co-authors of Mostafa Erfani

This figure shows the co-authorship network connecting the top 25 collaborators of Mostafa Erfani. A scholar is included among the top collaborators of Mostafa Erfani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mostafa Erfani. Mostafa Erfani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erfani, Mostafa, et al.. (2024). Technetium-99m radiolabeling of graphene quantum dots (GQDs) as a new probe for glioblastoma tumor imaging. International Journal of Radiation Biology. 101(1). 65–72. 4 indexed citations
2.
Erfani, Mostafa, et al.. (2020). Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluation. Bioorganic Chemistry. 102. 104050–104050. 34 indexed citations
3.
Erfani, Mostafa, et al.. (2018). Development of a 99m Tc-Labeled CXCR4 Antagonist Derivative as a New Tumor Radiotracer. Cancer Biotherapy and Radiopharmaceuticals. 33(1). 17–24. 12 indexed citations
4.
Erfani, Mostafa, et al.. (2018). Radiolabeling of zoledronic acid with 188Re as a new palliative agent radiotracer in treatment of bone tumors. Journal of Radioanalytical and Nuclear Chemistry. 316(2). 491–500. 4 indexed citations
5.
Ayati, Narjess, et al.. (2017). Diagnostic value of 99mTc-ubiquicidin scintigraphy in differentiation between osteomyelitis and bone tumors. Nuclear Medicine Communications. 38(11). 885–890. 4 indexed citations
6.
Mehrabi, Mohsen, Simindokht Shirvani‐Arani, Ali Bahrami‐Samani, et al.. (2016). Production, quality control, and determination of human absorbed dose of no carrier added 177Lu‐risedronate for bone pain palliation therapy. Journal of Labelled Compounds and Radiopharmaceuticals. 60(1). 20–29. 3 indexed citations
7.
Erfani, Mostafa, et al.. (2015). DEVELOPMENT OF A FREEZE-DRIED RADIOPHARMACEUTICAL KIT FOR DOPAMINE TRANSPORTERS IMAGING. 23(1). 15–20. 2 indexed citations
8.
Erfani, Mostafa, et al.. (2015). Efficacy of 99mTc-Ciprofloxacin and 67Ga-Citrate scintigraphy to discriminate infection foci induced by staphylococcus aureus from sterile inflammation induced by carrageenan in rat. 23(244). 96–102. 2 indexed citations
9.
Beiki, Davood, Fatemeh Karami, Babak Fallahi, et al.. (2015). EVALUATION OF A NEW 99MTC-BOMBESIN ANALOG IN DIFFERENTIATION OF MALIGNANT FROM BENIGN BREAST TUMORS. 23(244). 103–107. 3 indexed citations
10.
Fallahi, Babak, Davood Beiki, Shahram Oveisgharan, et al.. (2015). Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease versus other progressive movement disorders. Annals of Nuclear Medicine. 30(2). 153–162. 22 indexed citations
11.
Shamshirian, Danial, Mostafa Erfani, Davood Beiki, Babak Fallahi, & Mohammad Shafiei. (2015). Development of a 99mTc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors. Annals of Nuclear Medicine. 29(8). 709–720. 7 indexed citations
12.
Erfani, Mostafa, et al.. (2014). Viscous Fingering in LAPONITE® and Mud. Journal of Testing and Evaluation. 43(1). 11–17. 1 indexed citations
13.
Erfani, Mostafa & Mohammad Shafiei. (2014). Preparation of 99mTc-TRODAT-1 with high labeling yield in boiling water bath: A new formulation. Nuclear Medicine and Biology. 41(4). 317–321. 5 indexed citations
14.
Erfani, Mostafa, et al.. (2014). Clinical application of ultrasound for preparation of 99mTc-sestamibi complex. Annals of Nuclear Medicine. 29(3). 295–301. 2 indexed citations
15.
Erfani, Mostafa, et al.. (2013). Optimization condition in labeling of Ofloxacin with 99mTc and its biological evaluation in Staphylococcus aureus and Escherichia coli for infection imaging. 21(1). 1–6. 3 indexed citations
16.
Erfani, Mostafa, et al.. (2013). Preparation and Biological Evaluation of [ 99m Tc/EDDA/Tricine/HYNIC 0 , BzThi 3 ]-Octreotide for Somatostatin Receptor-Positive Tumor Imaging. Cancer Biotherapy and Radiopharmaceuticals. 28(3). 240–247. 7 indexed citations
17.
Erfani, Mostafa, et al.. (2013). Evaluation of a new bombesin analogue labeled with 99mTc as potential targeted tumor scintigraphic agent. 1(3). 13–18. 1 indexed citations
18.
Erfani, Mostafa, et al.. (2012). Synthesis and biological evaluation of 99mTc(CO)3-OH-PP-CS2 for brain receptor imaging. 20(1). 25–31. 8 indexed citations
19.
Aryana, Kamran, et al.. (2012). 99mTc-labeled ubiquicidin scintigraphy. Nuklearmedizin - NuclearMedicine. 51(4). 133–139. 23 indexed citations
20.
Erfani, Mostafa, et al.. (2010). FREEZE-DRIED COLD KIT FOR PREPARATION OF 99MTC-CIPROFLOXACIN AS AN INFECTION IMAGING AGENT. 18(2). 45–51. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon J. Henderson Breakdown of academic impact, for papers by A. Rinelli Breakdown of academic impact, for papers by Takashi Shirakawa Breakdown of academic impact, for papers by Christian Maaß Breakdown of academic impact, for papers by Jiawen Dai Breakdown of academic impact, for papers by Yewei Liu Breakdown of academic impact, for papers by Alison Acevedo Breakdown of academic impact, for papers by Paul Morrill Breakdown of academic impact, for papers by Yingxia Li Breakdown of academic impact, for papers by Hojin Jeong
Rankless by CCL
2026